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Lobuloalveolar differentiationFibronectin (Fn) plays an important part in the branching morphogenesis of salivary gland, lung, and kidney.
Here, we examine the effect of the conditional knockout of Fn in the mammary epithelium [FnMEp−/−] on
postnatal mammary gland development, using Cre-loxP-mediated gene knockout technology. Our data show
that Fn deletion causes a moderate retardation in outgrowth and branching of the ductal tree in 5-week-old
mice. These defects are partially compensated in virgin 16-week-old mice. However, mammary glands
consisting of Fn-deﬁcient epithelial cells fail to undergo normal lobuloalveolar differentiation during
pregnancy. The severity of lobuloalveolar impairment ranged from lobular hypoplasia to aplasia in some cases
and was associated with the amount of Fn protein recovered from these glands. Decreased rates of mammary
epithelial cell proliferation accounted for delayed ductal outgrowth in virgin and lack of alveologenesis in
pregnant FnMEp−/− mice. Concomitant decreased expression of integrin β1 (Itgb1) and lack of autopho-
sphorylation of focal adhesion kinase (Fak) suggest that this pathology might, at least in part, be mediated by
disruption of the Fn/Itgb1/Fak signaling pathway.edicine, College of Veterinary
3, USA. Fax: +1 607 253 3659.
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Fibronectin (Fn) is an adhesive glycoprotein that is present in
extracellularmatrices (insoluble form) and in bodyﬂuids (soluble form;
e.g., blood plasma). It exists as a dimer composed of nearly identical
~250 kDa subunits linked covalently near their C-termini by a pair of
disulﬁdebonds. Eachmonomer consists of 3 types of repeats: 12 type I, 2
types II, and 15 type III repeats (Hynes, 1990; Pankov and Yamada,
2002). Although Fn molecules are the product of a single gene, the
resulting protein can exist in multiple forms arising from alternative
splicing of a single pre-mRNA (~20 variants in humans). Splice sites are
EDA (Extra Domain A), EDB (Extra Domain B), and IIICS (type III
connecting segment; also called variable [V] region) (ffrench-Constant,
1995). This multidomain structure harboring binding sites for cell
adhesion receptors (e.g., integrins, syndecans, CD44, CD26), matrix
macromolecules (e.g., collagens, hyaluronic acid, proteoglycans, tenas-
cin, thrombospondin, ﬁbrinogen), secreted, biologically important
molecules (e.g., factor XIIIa, tissue transglutaminase, ﬁbrinogen,
heparin), as well as for Fn–Fn self-association makes it a perfect
candidate for a ‘multitask’ role (Danen and Yamada, 2001; Johansson
et al., 1997; Leiss et al., 2008; Wierzbicka-Patynowski and Schwarz-bauer, 2003). As such, it anchors the extracellular matrix to the cell
cytoskeleton via adhesion receptors and, in doing so, relays signals from
the milieu outside the cell to its inside. This so-called outside-in
signaling accounts for the many functions, with which Fn has been
associated including cell adhesion, differentiation, growth, and migra-
tion (Danen and Yamada, 2001; Geiger et al., 2001; Kumar, 1998; Leiss
et al., 2008). Thus, Fn is critical in vertebrate development, tissue
morphogenesis and homeostasis, wound healing, angiogenesis, and
cancer (Cheng et al., 2003; ffrench-Constant, 1995; Geiger et al., 2001;
Hynes, 1990; Kumar, 1998;Miyamoto et al., 1998; Pankov and Yamada,
2002). Not surprisingly, Fn knockout is embryologically lethal, with
abnormalities becoming manifest ﬁrst at the onset of gastrulation (for
details, see George et al., 1993; Watt and Hodivala, 1994).
Many organs, including glands, lung, and kidney, are formed during
embryonic development by epithelial branching through a process of
repetitive epithelial cleft and bud formations. In an elegant organ culture
study, Sakai et al. (2003) showed that Fn is essential for cleft formation
during the initiation of epithelial branching in the submaxillary gland. Fn
messenger RNA and ﬁbrils were expressed transiently and focally in
forming epithelial cleft regions. Knockdown of Fn by small interfering
RNA and by inhibition with anti-Fn or anti-integrin antibodies (anti-α5,
-α6, and -β1) blocked cleft formation and branching, while exogenous
Fnaccelerated cleft formationandbranching. Although a similar scenario
has not been established for the mammary gland, the functional role of
ECM proteins, including Fn, collagen type I, and laminin, in mammary
gland postnatal development has been studied more recently (Haslam
andWoodward, 2003). Among the three ECMproteins, only the Fn levels
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maturity and remaining high during pregnancy and lactation. This
temporal expression of Fn coincided with increased expression of select
growth factors and AP-1 transcription factors as well as estrogen and
progesterone (Fendrick et al., 1998; Haslam andWoodward, 2003; Shen
et al., 2006; Wang et al., 1994; Woodward et al., 1998, 2001; Yang et al.,
1995). Together, these compounds are involved in ductal development
during puberty and mammary epithelial cell proliferation, ductal
branching, and alveologenesis at sexual maturity and during pregnancy
(Fendrick et al., 1998; Woodward et al., 1998), while AP-1 blockade
suppresses ductal branching and budding and reduces gland tree size
and fat pad occupancy in developing mammary glands by inhibiting
expression of AP-1-dependent genes (e.g., Fn, cyclin D, c-myc, TIMP-1,
vimentin) (Shen et al., 2006).
To determine the precise role of Fn in postnatal mammary gland
development, we have conditionally deleted this gene in mouse
mammary epithelium, using the Cre-loxP mediated approach. Our
whole-mount, histological, immunohistochemical, morphometric, bio-
chemical, and functional data show that Fn deletion delays the
branching morphogenesis and impairs lobuloalveolar differentiation
during pregnancy. This pathology is duplicated in mice transplanted
with mammary epithelial cells isolated from FnMEp−/− mice and is
associated with signiﬁcantly decreased rates of mammary epithelial
proliferation. Preliminary evidence suggests that altered signaling via
the β1 integrin (Itgb1) Fn receptor and focal adhesion kinase (Fak)may
haveultimately accounted for themammary glandpathology associated
with Fn deletion.
Materials and methods
Generation of mice with mammary-speciﬁc Fn gene deletion
Mice carrying loxP sites within the 5′ untranslated region at the
Msc1 site andwithin the ﬁrst intron at theNhe1 site of the Fn genewere
generated in Dr. Fässler's laboratory (Sakai et al., 2001). Tg(MMTV-Cre)
22Mam, Line F (MMTV-Cre) mice (Wagner et al., 1997) were used for
expression of Cre recombinase in themammary epithelium. Thesemice
were obtained from the Mouse Models of Human Cancers Consortium
(NIH/NCI). After backcrossing to the FVB/N background, male MMTV-
Cre mice were paired with Fnﬂ/ﬂ females in order to obtain MMTV-Cre
Fnﬂ/ﬂmice. Depending on their homozygous or heterozygous status for
theﬂoxed Fn allele, thesemicewere designated FnMEp−/− or FnMEp+/−,
respectively. Nonrecombinant littermates were used as a control.
Rosa26StopﬂLacZ reportermice (Gt(ROSA)26SorTM1sor)werepurchased
from the Jackson Laboratory (Bar Harbor, ME). In these mice, the
expressionof bacterialβ-galactosidase is possible only after deletionof a
stop codon ﬂanked by loxP sites (Jiang et al., 2000). All mice were
maintained identically following recommendations of the institutional
Laboratory Animal Use and Care Committee.
Genotyping
Offspringwith the desiredgenotypeswere identiﬁed by PCRanalysis
of tail DNAusing primer sets from regionsﬂanking the Fn1 lox-P sites as
described by Sakai et al. (2001). PCR of ﬂoxed Fn results in a 1200-bp
DNA fragment, while Fn deletion results in a 320-bp band. MMTV-Cre
mice were identiﬁed by primers Cre-5′ (5′ GGA CAT GTT CAG GGA TCG
CCA GGC G 3′) and Cre-3′ (5′ GCA TAA CCA GTG AAA CAG CAT TGC TG
3′). PCR ampliﬁcation of Cre results in a 296-bp DNA fragment. The PCR
temperature proﬁle was 94 °C for 30 seconds, 60 °C for 1 min, and 72 °C
for 2 min with extension of the last cycle for 10 min at 72 °C.
X-gal detection
Frozen sections (5 μm thick) of the mammary glands fromMMTV-
Cre Gt(ROSA)26SorTM1sor mice and control nonrecombinant mateswere stainedwith X-gal solution as described by Bonnerot and Nicolas
(1993). Sections were counterstained with Nuclear Fast Red. Controls
were mammary glands from Rosa26STOPloxPLacZ mice. To further
assess organ speciﬁcity of the MMTV-Cre-mediated Fn knockout in
mammary glands, DNA was extracted from lung (Lu), heart (He),
kidney (Ki), mammary gland (MG), salivary gland (SG), uterus (Ut),
and liver (Li) of FnMEp−/− mice and subjected to PCR as described
above.
Mammary gland whole mount preparation, staining, and analyses
The left fourth inguinal mammary fat pad (MFP) was excised
essentially asdescribedbyTiran andElson (2003). In brief, excisedMFPs
were spread onto glass slides and ﬁxed with Tellyesniczky's ﬁxative
overnight. MFPs were then soaked in three changes of 100% acetone
each for 6 h, followed by 2-h treatments with each 100%, 95%, and 70%
ethanol, and stained with 0.2% carmine red overnight. After rinsing in
water, MFPs were dehydrated sequentially in 50%, 70%, 95%, and 100%
ethanol each for 2 h, cleared with methyl salicylate overnight and
examined under a dissecting microscope. Mammary gland whole
mounts were evaluated as follows: (i) Extent of ductal outgrowth:
maximal outgrowth beyondMFP lymph nodemeasured inmillimeters;
(ii) number of ductal branch points per unit area ofMFP; (iii) number of
terminal end buds (TEBs) inmammary glands from 5-week-oldmice as
described by Shen et al. (2006); and (iv) size and number of alveolar
lobules from mammary glands of pregnant mice. A minimum of seven
mice per age category and genotype were analyzed.
Histological and morphometric techniques
The right fourth inguinal MFP was excised as described above,
spread onto glass slides, and ﬁxed with phosphate-buffered 4%
paraformaldehyde overnight at 4 °C. MFPs were then subjected to
routine parafﬁn embedding, and 4-μm-thick, planar sections stained
with hematoxylin & eosin (H&E) or 0.1% Sirius Red/0.1% Fast Green in
1.2% picric acid to depict the extent of collagenous extracellular
matrix. Sections were scanned with the ScanScope (Aperio Technol-
ogies, Inc., Vista, CA) and evaluated as follows: (i) assessment of the
tissue architecture and branching pattern and (ii) estimation of the
volume density (VMG) of the glandular structures occupying the MFP
as described by Weibel and Bolender (1973) and Pauli et al. (1983),
using computer-enlarged photographs from entire MFP sections and
superimposed test lattices of 1-cm2 subunits: VMG=Pi (number of
line intersection points falling on mammary gland components) / PT
(total number of intersection points falling on both mammary gland
components and MFP stroma) (Pauli et al., 1983). A minimum of
seven mice per age category and genotype were analyzed.
Immunohistochemistry and immunoﬂuorescence
Five-micrometer-thick, paraformaldehyde-ﬁxed parafﬁn sections
from the right fourth inguinal MFP mounted on poly-L-lysine-coated
glass slides were used for immunohistochemical analyses. After
standard deparafﬁnization, sections were treated sequentially with 1%
pepsin in 10 mM HCl (pH 2.0; 30 min; 37 °C; Sigma-Aldrich, St. Louis,
MO) for antigen unmasking and MOM Ig blocking reagent (Vector
Laboratories, Burlingame, CA) for blocking endogenous immunoglob-
ulin in cases using mouse primary antibodies. Staining was then
performed using VECSTATIN Elite ABC kits (Vector Laboratories)
according to the manufacturer's instructions. Primary antibodies were
rabbit anti-Fn (Sigma-Aldrich), mouse anti-cytokeratin 8 (CK8) (Santa
Cruz Biotechnology, Santa Cruz, CA), and rat anti-mouse CD31 (BD
Biosciences, San Jose, CA) antibodies. Secondary antibodies were
biotinylated “Universal” anti-mouse/rabbit IgG made in horse and
biotinylated anti-rat IgG made in rabbit (included in VECSTATIN
Elite ABC kit). Sections were counterstained with hematoxylin. Control
Fig. 1. Conditional knockoutof Fn inmammaryepithelia. (A)DNAwas extracted from lung
(Lu), heart (He), kidney (Ki), mammary gland (MG), salivary gland (SG), uterus (Ut) and
liver (Li) of MMTV-Cre+Fnﬂ/ﬂ mice. PCR was performed with the primers designed from
the regions ﬂanking the Fn loxP sites. Fn deletion results in a 320-bp band, while ﬂoxed Fn
in a 1200-bp band. (B) Frozen section from themammary gland of a 16-week-oldMMTV-
Cre/Rosa26STOPloxPLacZ mouse stained with X-Gal solution (Fermentas) and counter-
stained with Fast Red. Notice the select expression of Cre-recombinase activity in MEp,
but not surroundingstromal cells. (C)X-Gal stainingof a frozensection fromthemammary
gland of a 16-week-old Rosa26STOPloxPLacZ control mouse. X-Gal staining is negative.
(D) Fn protein expression in Fnﬂ/ﬂ (lane 1) and FnMEp−/−mice (lanes 2–4), characteristic
of the mosaic expression of Cre in mammary epithelial cells. Bars: 50 μm (B and C).
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of primary antibody.
For immunoﬂuorescence analyses, primary antibodies were rabbit
anti-Fn and mouse anti-CK8 IgG, and secondary antibodies were
phycoerythrin-conjugated donkey anti-rabbit IgG and FITC-conjugat-
ed donkey anti-mouse IgG antibodies (Jackson ImmunoResearch
Laboratories, West Grove, PA). Control sections were stained with
normal rabbit or mouse IgG instead of primary antibody.
Assessment of mammary epithelium proliferative and apoptotic rates
The mammary epithelium proliferative rate was estimated by BrdU
assay. In brief,micewere injectedwith0.1 ml/10 g bodyweight of BrdU
solution (Invitrogen, Carlsbad, CA) 2 h before sacriﬁce. BrdU-positive
cells were detected by immunohistochemistry using anti-BrdU anti-
body (1:150 dilution; 1.5 h; 37 °C) (Invitrogen). The general prolifer-
ative ratewas expressed as the percent of BrdU-positive cells of the total
number of mammary epithelial cells counted (600 cells/mammary
gland). Ductal epithelial cell proliferation was expressed as the number
of BrdU-positive mammary epithelial cells per 500 μm of ductal
circumference, measuring the long and short axes of a ductal cross
section and calculating the circumference according to the following
Web site: http://www.csgnetwork.com/circumellipse.html.
The mammary epithelium apoptotic rate was determined by the
cleaved caspase 3 immunohistochemical assay (Shen et al., 2006). The
anti-cleaved caspase 3 antibody was from BD Biosciences (San Jose,
CA) and was used at a dilution of 1:150 as described above. The
percent of cleaved caspase 3-positive cells of the total number of
mammary epithelial cells (~1000 cells counted) was used as an
expression of the mammary epithelium-apoptotic rate.
Transplantation experiments
Twelve 8- to 12-week-old virgin FnMEp−/− and Fnﬂ/ﬂ mice served
as mammary epithelium donors. Mammary epithelial cells were
isolated essentially as described by DeOme et al. (1959) and Brill et al.
(2008) with some modiﬁcations. Donor MFPs were excised as
described above, minced into small fragments (~1 mm3), and
digested with 0.3% collagenase type 3 (Worthington Biochemical,
Lakewood, NJ) and 0.1% hyaluronidase (Sigma) in DMEM containing
0.2% bovine serum albumin (BSA) for 8 h at 37 °C in end-over-end
suspension. After lysing red blood cells with 125 mM ammonium
chloride in DMEM, the digest was centrifuged (450×g; 5 min), and
the pellet was further digested in sequential solutions of Trypsin–
EDTA (0.25%/0.02%) for 1–3 min (gentle up-and-down pipetting),
and 0.25% dispase (Worthington Biochemical) for 5 min, both in HBSS.
The ﬁnal digest was passed through a 40-μm nylon mesh (Tetko,
Depew, NY). Cells were then cultured for 3 days in collagen-coated
dishes in DMEM containing 5% fetal bovine serum (FBS), epidermal
growth factor (10 ng/ml; Sigma-Aldrich), and insulin (1 μg/ml;
Sigma-Aldrich). Cells were harvested by standard trypsin/EDTA
treatment and adjusted to 5×104 cells/20 μl HBSS. Recipient mice
were six 3-week-old female FVB mice, whose left and right fourth
MFPs had been cleared as described by Brill et al. (2008). The sites of
the left, cleared MFPs were inoculated with mammary epithelial cells
harvested from MMTV-Cre+-Fnﬂ/ﬂ mice and the sites of the right,
cleared MFPs with mammary epithelial cells harvested from MFPs of
Fnﬂ/ﬂ mice. Recipient mice were mated at 8 weeks of age, and their
MFPs removed after 15 days of pregnancy. Analysis of the MFPs was
by whole mount and histological examinations. A total of nine mice
were analyzed.
Vegf expression measured by RT–PCR
Total RNA was extracted from the mammary glands of 4-month-
old and 15-day pregnant Fnﬂ/ﬂ and FnMEp−/− mice, using TRIzol as
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quantiﬁed both spectrophotometrically and electrophoretically, and
amounts adjusted so that 1 μg was reverse-transcribed (SuperScript
reverse transcriptase; Invitrogen). cDNA was subjected to PCR (93 °C,
30 s; 55 °C, 30 s; 72 °C, 30 s; 35 cycles) using Taq DNA polymerase
(Invitrogen). Primers were 5′-GGAGAGCAGAAGTCCCATGA-3′ and 5′-
ACTCCAGGGCTTCATCGTTA-3′. Controls were run in the absence of
reverse transcriptase. Gapdh served as reference standard (primers: 5′-
ACGACCCCTTCATTGACCTC-3′ and 5′-CTTTCCAGAGGGGCCATCCAC-3′).
Biochemical analyses
Mammary epithelial cells were isolated from MFPs of 15-day
pregnant MMTV-Cre+Fnﬂ/ﬂ and Fnﬂ/ﬂ mice as described above (Brill
et al., 2008; DeOme et al., 1959). Cells were used for biochemical
analyses after a 3-day culture period on Matrigel-coated culture dishes
in DMEMcontaining 5% FBS, 25 ng/ml EGF, and 1 μg/ml insulin (Sigma-
Aldrich). To determine Fn protein levels and assess the role of the
downstream Fn signaling partners in the lobuloalveolar differentiation
of themammary gland, cellswere extracted in lysis buffer (50 mMTris–
HCl, pH7.4, 150 mMNaCl, 1 mMEDTA, 1 mMEGTA, 1 mMbenzamidine
chloride, 1 mMPMSF, 2 μg/ml leupeptin, 0.27 TIU/ml aprotinin, 0.1 mM
sodium vanadate, and 1% Triton X-100) for 1 h at 4 °C (Abdel-Ghany
et al., 2002). Total cell lysates were subjected to SDS–PAGE (~20–50 μg
protein) andWesternblotting, usinganti-Fn (Sigma-Aldrich), anti-Itgb1
(Santa Cruz Biotechnology), and anti-focal adhesion kinase (FAK) and
anti-Fak(pY397) primary antibodies (both from Enzo Life Sciences
International, Plymouth Meeting, PA). Secondary antibodies were HRP-
conjugated donkey anti-rabbit or goat anti-mouse antibodies (Jackson
ImmunoResearch Laboratories). ECL for detection of bound antibody
was as described previously (Abdel-Ghany et al., 2002).
Statistical analyses
The signiﬁcance of the mean differences among the three mouse
groups (Fnﬂ/ﬂ; FnMEp+/−; FnMEp−/−) was evaluated using the analysis
of variance statistical technique (ANOVA). If we rejected the null
hypothesis of no signiﬁcant differences among the groups, we
performed a post-hoc test using the Tukey's multiple comparison test
to identify which two groups were signiﬁcantly different from each
other. All statistical analyses were performed using the statistical
software Statistix 9.0 (Analytical Software, Tallahassee, FL) at pb0.05.
For two-group (Fnﬂ/ﬂ; FnMEp−/−) comparisons, Student's t-test for
unpaired data was used (pb0.05). All data are displayed as mean±
standard error (SE).
Results
Conditional knockout of Fn in mouse mammary epithelium and
assessment of MMTV-Cre mediated recombination
To assure selectivity of Cre-recombinase activity in the mammary
epithelium several approaches were used. First, Cre-mediated
deletion of ﬂoxed Fn was assessed by PCR of DNA isolated from the
lung, heart, kidney, liver, uterus, mammary gland, and salivary gland
of FnMEp−/− and FnMEp+/− mice and their nonrecombinant litter-
mates (Fnﬂ/ﬂ). In agreement with Wagner et al. (1997), among the
tested organs, only the mammary and the salivary gland of FnMEp−/−Fig. 2. Mammary gland whole mounts from Fnﬂ/ﬂ and FnMEp−/− virgin mice and quantiﬁca
retardation in the ductal outgrowth, decreased branching, and decreased numbers of TEBs i
and branching in FnMEp−/−mice appear to be similar to those in Fnﬂ/ﬂmice. (B)Mammary gl
(C and F) and to count the number of branch points of outgrowing ducts (D and G) in 5- (
counted were the number of TEBs (E) in 5-week-old mice from the three groups of mice. N
FnMEp−/− relative to FnMEp+/− and Fnﬂ/ﬂ mice at 5 weeks (C, D, and E). Ductal outgrowth a
not different from those in Fnﬂ/ﬂ mice due to greater sample variability (F and G). Group siz
groups were indicated by connecting brackets and asterisk.mice exhibited strong Cre activity as visualized by deletion of the
ﬂoxed Fn segment (320 bp band) in these organs (Fig. 1A). In contrast,
heterozygous FnMEp+/− mice exhibited both Fn species (i.e., deleted
[320 bp] and undeleted [1.2 kb] ﬂoxed-Fn) and Fnﬂ/ﬂ mice revealed
only undeleted, ﬂoxed Fn as expected (data not shown). Second, to
further assess the selectivity of Cre recombinase activity and
expression in the mammary epithelium, MMTV-Cre+ male mice
were crossed with Rosa26STOPﬂLacZ females, and frozen sections
from the mammary glands of MMTV-Cre+- Rosa26STOPﬂLacZ and
Rosa26STOPﬂLacZ (control) mice were stained with X-gal. X-gal
staining was only observed in the mammary epithelium fromMMTV-
Cre+- Rosa26STOPﬂLacZ mice, where Cre recombinase activity
removed a ﬂoxed stop colon to allow expression of LacZ (Fig. 1B).
The extent of Cre expression in mammary epithelium ranged from
50% to 100%, which is consistent to that reported by Wagner et al.
(1997). No X-gal staining was observed in nonepithelial tissues. Age-
matched, Cre-negative control mice revealed no X-gal staining of the
mammary epithelium (Fig. 1C).
To examine Fn protein expression we selected mammary glands
(or sections thereof) from 15-day pregnant Fnﬂ/ﬂ and FnMEp−/−mice
since at this stage mammary glands of normal mice express relatively
high levels of Fn (Haslam and Woodward, 2003). As expected, Fnﬂ/ﬂ
mice exhibit strong Fn protein expression, while the amount of Fn
protein in FnMEp−/− mice varied from approximately 0 (nondetect-
able) to 50%–60% of that measured in MFPs from Fnﬂ/ﬂmice (Fig. 1D).
This variation is due to the mosaic nature of Cre expression.
Fn deletion results in delayed mammary branching morphogenesis
Carmine red-stained MFPs from 5- and 16-week-old, virgin Fnﬂ/ﬂ,
FnMEp+/−, and FnMEp−/− mice were analyzed qualitatively and
quantitatively. At 5 weeks of age, mammary glands of FnMEp−/−
mice exhibited a statistically signiﬁcant retardation in ductal
outgrowth (Figs. 2A and C) as well as decreased numbers of branch
points (Figs. 2A and D) and terminal end buds (TEBs) (Figs. 2B and E)
relative to Fnﬂ/ﬂ and, with the exception of ductal outgrowth, to
heterozygous FnMEp+/− mice (Figs. 2A–E). These abnormalities were
somewhat compensated at 16 weeks of age, as no statistical differ-
ences in the length of ductal outgrowth (p=0.07652) and number of
branch points were observed between Fnﬂ/ﬂ and FnMEp−/− mice
(Figs. 2A, F, and G).
Histological examination of planar sections prepared from mam-
mary glands of mice of the same groups complemented our ﬁndings
from mammary gland whole mounts. At both 5 and 16 weeks of
age, there was a decrease in the mean number of ductal cross sections
in FnMEp−/− relative to Fnﬂ/ﬂ mice that was most prominent in
micrographs taken from areas distal of the MFP lymph node (Ln)
(Figs. 3A–E). However, the retarded outgrowth of delicate (linear)
ductal strands did not have a signiﬁcant effect on the volume percent
of glandular tissue occupying the MFP (Figs. 3F and G).
Fn deletion causes decreased mammary epithelial cell proliferation
resulting in pregnancy-associated lobuloalveolar hypoplasia/aplasia
The effect of Fn deletion on mammary gland postnatal develop-
ment is most dramatic during pregnancy. Mammary gland whole
mounts of 15-day pregnant FnMEp−/− mice exhibited near-normal
ductal development and branching, extending from the nipple up totion of ductal outgrowth and branching and TEBs. (A) At 5 weeks, there is a noticeable
n FnMEp−/− relative to Fnﬂ/ﬂ mice. At 16 weeks (virgin mice; v16w), ductal outgrowth
andwholemounts were used tomeasure ductal outgrowth beyond theMFP lymph node
C and D) and 16-week-old (F and G) Fnﬂ/ﬂ, FnMEp+/−, and FnMEp−/− virgin mice. Also
otice retarded ductal outgrowth and decreased numbers of branch points and TEBs in
nd branching were still decreased in 16-week-old FnMEp−/−mice but were statistically
e: ≥7 mice; Mean; SE; Bar: 1 mm (A and B). Statistical differences at pb0.05 between
15K. Liu et al. / Developmental Biology 346 (2010) 11–24the terminal ductules, but lobuloalveolar differentiation, typically
observed at this stage of pregnancy in normal and Fnﬂ/ﬂ mice, was
seriously compromised (Fig. 4A). Alterations varied greatly andranged from the assembly of rudimentary lobuloalveolar structures
(hypoplasia) in select lobules to a total absence of the lobuloalveolar
compartment (aplasia). In general, the degree of lobuloalveolar
Fig. 3. Planar section of mammary glands from virgin Fnﬂ/ﬂ and FnMEp−/−mice stained with H&E. (A, B, and C) At 5 weeks (5w), there is a noticeable decrease in the number of ductal
cross-sections distal of the mammary gland lymph node (Ln) in FnMEp−/− (B) relative to Fnﬂ/ﬂ mice (A). This difference is not signiﬁcant proximal to the Ln (C; compare with
Fig. 2A). (D and E) At 16 weeks (virgin, v16w), mammary glands from Fnﬂ/ﬂmice exhibit a near-normal density of ductal cross sections and indications of alveolar [a] differentiation
(D), while mammary glands from FnMEp−/−mice show slightly decreased numbers of ductal cross sections [D] and branching ductules [d] and no clear signs of alveolar development
(E). (F and G) Estimation of the volume percent of glandular tissue (VMG) occupying themammary fat pad (see Materials andmethods) in 5- and 16-week-old, virgin mice: Although
the mean VMG is the smallest in FnMEp−/−mice it is statistically not different from that in FnMEp+/− and Fnﬂ/ﬂ mice, showing that the observed delayed ductal outgrowth does not
signiﬁcantly effect this parameter. Group size: 7 mice/group. Mean±SE; Bars: 50 μm.
16 K. Liu et al. / Developmental Biology 346 (2010) 11–24hypoplasia correlated well with the amount of Fn protein recovered
from these glands (compare Fig. 1D, lanes 2–4, and Fig. 4B of the same
FnMEp−/− mice).
Histopathologically, there was normal lobuloalveolar differentia-
tion in pregnant Fnﬂ/ﬂ mice (Figs. 5A, D, and F). Alveoli were budding
out from patent terminal ductules (Fig. 5D) and associated closely
with each other to form lobules (Fig. 5A). They were separated by
scant vascularized, ﬁbrous connective tissue (Fig. 5F) and their
epithelia contained typical lipid globules (Fig. 5A). Associatedsmall ducts and terminal ductules were patent and often ﬁlled with
secretory products and were enveloped with a ﬁnely ﬁbrillar
collagenous extracellular matrix (Fig. 5F). In contrast, FnMEp−/−
mice either failed to undergo lobuloalveolar development entirely
(Fig. 5B) or formed loose clusters of alveoli that varied in number
between lobules and that were often totally ﬁlled with epithelial cells
(Fig. 5C). In the absence of alveoli, small ducts and terminal ductules
were almost completely collapsed and were surrounded with
abundant, collagenous connective tissue (Fig. 5G). Consistent with
Fig. 4. Lobuloalveolar hypoplasia/aplasia of the mammary gland in pregnant FnMEp−/−mice. (A and B) Carmine red-stained mammary gland whole mounts from 15-day pregnant
Fnﬂ/ﬂ and FnMEp−/−mice. (A) Sets of low- and high-power views from themammary gland showing extensive lobuloalveolar differentiation in Fnﬂ/ﬂmice and severe lobuloalveolar
hypoplasia in FnMEp−/− mice. Bar: 1 mm. (B) There are various degrees of lobuloalveolar hypoplasia ranging from moderate hypoplasia (left-hand panel) to aplasia (right-hand
panel), the latter depicting a skeleton of branching ducts only and no signs of lobuloalveolar growth in FnMEp−/− mice. This pathology corresponds with loss of Fn protein (see
Fig. 1D, same glands). Also notice that the branch density and pattern are unaffected. Bar: 0.5 mm.
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the glandular volume percent occupying the MFP in FnMEp−/− mice
that is statistically signiﬁcantly different from that in both Fnﬂ/ﬂ and
heterozygous FnMEp+/− mice (Fig. 5H).
To examine whether failure of generating the lobuloalveolar
compartment in pregnant FnMEp−/− mice was due to decreased
proliferation and/or increased apoptosis of mammary epithelial cells
in FnMEp−/− mice, we performed BrdU incorporation and cleaved
caspase-3 assays, respectively. Results show a signiﬁcant decrease in
the overall percentile of BrdU-positive mammary epithelial cells in
pregnant FnMEp−/−mice relative to pregnant Fnﬂ/ﬂmice (Figs. 6A–C).
Since this result might be skewed by the presence of a normal
lobuloalveolar compartment in Fnﬂ/ﬂ mice and a moderately to
severely compromised lobuloalveolar compartment in FnMEp−/−
mice, we also counted the number of BrdU-positive epithelial cellsper 500 μm of ductal circumference in the same mice. Again, these
counts were signiﬁcantly lower in ductal epithelial cells from FnMEp−/−
relative to those from Fnﬂ/ﬂ mice (Figs. 6D–F). Decreased numbers
of BrdU-positive ductal epithelial cells were also observed in 16-week-
old, virgin FnMEp−/− mice relative to age-matched Fnﬂ/ﬂ mice (Suppl.
Fig. 1). Interestingly, values of ductal epithelial cell incorporation of
BrdU in Fnﬂ/ﬂ and FnMEp−/− mice during pregnancy (Fig. 6F) were
higher than in virgin, 4-month-old mice of the same genotypes (Suppl.
Fig. 1), correlating with increased Fn expression by pregnancy-
associated hormonal conditions (Woodward et al., 2001) during
alveologenesis (Williams et al., 2008). Together, our data indicate that
Fn deletion caused a signiﬁcant decrease in the rate of mammary
epithelial cell proliferation that accounted for the delay in ductal
outgrowth in adult, virgin, and impaired alveologenesis in pregnant
FnMEp−/−mice.
Fig. 5. Histologic and quantitative details of lobuloalveolar differentiation in Fnﬂ/ﬂ and FnMEp−/−mice. (A, B, and C) H&E-stained planar sections of the mammary gland from 15-day
pregnant Fnﬂ/ﬂ and FnMEp−/−mice: There is extensive lobuloalveolar differentiation in Fnﬂ/ﬂ mice (A) and lack thereof in FnMEp−/−mice as shown by the presence of ductal cross
sections only (B) or the presence of groups of aberrant pseudoalveolar structures consisting of solid clusters of epithelial cells (C). (D and E) Hematoxylin-stained section of the
mammary gland from Fnﬂ/ﬂ (D) and FnMEp−/− (E) mice at 10 days of pregnancy: (D) Three terminal ductules (T) are sprouting from a common small duct and begin to differentiate
into several alveoli (early lobule formation) in Fnﬂ/ﬂmice; (E) Stubby terminal ductules (T) sprouting from a common small duct: notice that terminal ductal buds are not patent, but
ﬁlled with epithelial cells (arrow); there is no alveolar budding in the depicted lobule. (F and G) Sirius Red/Fast Green-stained section from Fnﬂ/ﬂ (F) and FnMEp−/− (G) mice:
(F) There is a modest collagenous matrix surrounding small, ﬂuid-ﬁlled ducts and a scant, interalveolar matrix in Fnﬂ/ﬂ mice; (G) Extensive collagenous matrix surrounds small,
collapsed ducts and terminal ductules in FnMEp−/−mice. (H) As expected, the VMG is signiﬁcantly smaller in pregnant FnMEp−/−mice than in Fnﬂ/ﬂ mice. Mean±SE. Bars: 100 μm.
18 K. Liu et al. / Developmental Biology 346 (2010) 11–24
Fig. 6. Fn deletion suppresses mammary epithelial cell proliferation, accounting at least
in part for the lack of lobuloalveolar differentiation. BrdU staining of mammary gland
sections from a 15-day pregnant Fnﬂ+/+ mouse (A) and a 15-day pregnant FnMEp−/−
mouse (B), both injected 2 h before euthanasia with 100 μg BrdU/g of BW. There is
extensive BrdU-staining of mammary epithelial cells in the Fnﬂ/ﬂmouse (A) and minor
staining of ductal epithelial cells in the FnMEp−/−mouse (B). Bars: 10 μm. (C) There is a
signiﬁcant decrease in the overall number of BrdU-positive mammary epithelial cells in
FnMEp−/−mice relative to control Fnﬂ/ﬂmice (counts are from 600mammary epithelial
cells in each of≥3mice per category). BrdU staining of ductal epithelial cells in a 15-day
pregnant Fnﬂ+/+ mouse (D) and a 15-day pregnant FnMEp−/− mouse (E), showing
decreased numbers of BrdU-positive ductal epithelial cells in the FnMEp−/− mouse.
(F) Numbers of BrdU-positive cells per 500 μm of ductal circumference were counted as
described inMaterials andmethods. There is a signiﬁcant decrease in the number of BrdU-
positive ductal epithelial cells in FnMEp−/− relative to Fnﬂ/ﬂ mice. Mean±SE; pb0.05.
Fig. 7. Transplants of FnMEp−/− mammary epithelial cells into normal syngeneic mice
exhibit the same mammary gland pathology as that in FnMEp−/− mice. Mammary
epithelial cells isolated from Fnﬂ/ﬂ and FnMEp−/− mice, respectively, were injected in
the cleared 4th MFP from 3-week-old recipient FVB mice as described in Materials and
methods. (A) Transplants from mammary epithelial cells of Fnﬂ/ﬂ mice produced
mammary glands with normal lobuloalveolar development during pregnancy.
(B) Transplants originating from mammary epithelial cells of FnMEp−/− mice exhibit
deﬁcient lobuloalveolar differentiation (moderate hypoplasia) in 15-day pregnant
recipient mice that paralleled the level of Fn expression in the MFP donor cell isolate.
Bar: 0.5 mm.
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(data not shown), albeit a few shrunken or fragmented nuclei were
noticeable inmammary epithelial cells from pregnant FnMEp−/−mice.
Changes in the mammary gland do not depend on Fn deletion in other
tissues
To exclude the possibility that MMTV-Cre transgene expression in
other tissues, most notably in the hematopoietic system (Wagner
et al., 1997), may have affected our data, we examined whether a
similar pathology to that depicted in 15-day pregnant FnMEp−/−mice
(Figs. 4A and B) could be reproduced in transplantation experiments.
To do this, we injected the cleared fourthMFP of recipient FVBmice at
3 weeks of age with mammary epithelial cells isolated from FnMEp−/−
or Fnﬂ/ﬂ donor mice. Carmine red-stained mammary gland whole
mounts were then analyzed at day 15 of pregnancy (Figs. 7A and B).
Data show a degree of lobuloalveolar hypoplasia that paralleled the
loss of Fn protein in mammary epithelial cell isolates from thecombined group of FnMEp−/− donor mice (Fig. 7B). In contrast,
mammary epithelial cell isolates from Fnﬂ/ﬂ donor mice generated
mammary gland transplants with normal lobuloalveolar development
(Fig. 7A).
Fn-mediated impaired alveologenesis is associated with decreased
neovascularization
Normal alveologenesisis is thought to proceed by repetitive
epithelial cleft and bud formation (Sakai et al., 2003). This process
appears to be initiated by the deposition of wedges of Fn-positive
material in clefts in the CK8-positive epithelial lining of a budding
alveolus as shown in the mammary gland of a 15-day pregnant Fnﬂ/ﬂ
mouse and is followed by the in-growth of vascularized mesenchyme
to further separate budding alveoli (Figs. 8A–C, arrows). At the same
time, new alveolar structures appear also to be formed by the
‘outgrowth’ of epithelial cells from deﬁned sectors of existing alveoli
(Figs. 8D–F). These cells are polygonal in shape, are weakly CK8-
positive, and their surfaces are decorated with a delicate rim of Fn-
positive material (Fig. 8E). In contrast, deletion of Fn in mammary
epithelial cells is associated with the sparse deposition of ﬁnely
ﬁbrillar Fn-positive material in a dense collagenous extracellular
matrix that surrounds small ducts and ductules (Figs. 5G and 8G–I).
Interestingly, many of these ductular cross sections lack a lumen and
instead are ﬁlled entirely with CK8-positive epithelial cells (Fig. 8G).
To further explore the role of neovascularization in mammary gland
alveologenesis in pregnant Fnﬂ/ﬂ mice, we stained sections from
mammary gland lobules with anti CD31 and anti-Fn antibodies. Blood
vessels form an intricate CD31-positive capillary network that
surrounds alveoli in a honeycomb pattern (Fig. 9A). They are closely
Fig. 8. Fn deletion suppresses alveolar budding during pregnancy. Five-micrometer-thick sections from mammary glands of 15-day pregnant Fnﬂ/ﬂ (A–F) and FnMEp−/−mice (G–I)
were immunostained as described in Materials and methods; green ﬂuorescence: CK8 (A, D, G); red ﬂuorescence: Fn (B, E, H); merged CK8/Fn (C, F, I). (A) Cluster of alveoli with
anti-CK8-positive epithelia in a Fnﬂ/ﬂmouse: Notice that there is generation of new alveoli from an existing alveolus by alveolar budding (arrows) and release of CK8-positive cells
from the epithelial lining of existing alveoli that penetrate surrounding stroma (center view: arrowheads). (B) Same epithelial cluster as in (A) stained with anti-Fn: Fn is prominent
around fully developed alveoli (predominantly at the base of epithelia and around blood vessels) and in clefts between alveolar buddings (arrows) and is expressed weakly at the
periphery of invading CK8-positive cells (arrow heads). (C) Merged A+B: Coexpression of CK8 and Fn in invading epithelial cells (arrowheads). (D, E, F) Details of A, B, and C:
Enlarged area (outlined in A) shows the formation of new alveoli by the outgrowth of weakly CK8-positive (D) and Fn-positive (E), polygonal cells from existing alveoli (arrows):
notice Fn staining on the cell surface and in the perinuclear area of outgrowing cells. (F) There is signiﬁcant coexpression of CK8 and Fn in areas of cellular outgrowth. (G) CK8-
positive mammary epithelial cells in collapsed small ducts and ductules in an FnMEp−/−mouse. (H) Faint Fn staining around ductal cross sections. (I) There is no colocalization of CK8
and Fn. Bars: 10 μm (A–I).
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alveologenesis (Fig. 9B). In contrast, blood vessels in pregnant FnMEp−/−
mice with severely compromised lobuloalveolar development are
restricted to the ﬁbrous connective capsule that envelops ductal cross
sections (Figs. 9C and 5G). Accordingly, Vegf expression, which is
primarily expressed by epithelial and myoepithelial cells and in only
minor amounts in stromal cells (Pepper et al., 2000), was signiﬁcantly
lower in pregnant FnMEp−/− than Fnﬂ/ﬂmice (Fig. 9D) butwas similar in
adult, virgin mice of the same genotypes (Suppl. Fig. 2), in which the
volume percent of glandular tissue occupying the fat pad was similar.
Albeit these data may suggest that low Vegf expression levels merely
reﬂect the loss of alveolar epithelial cells in the mammary glands from
pregnant FnMEp−/− mice, its role as a Fn-dependent factor inalveologenesis (Khan et al., 2004, 2005; Rossiter et al., 2007; Qiu et al.,
2008; Zhou et al., 2008) cannot be excluded, given the close association
between Fn deposits and capillary endothelial cells at the base of
emerging alveoli (Fig. 9B).
Fn, integrin β1, and focal adhesion kinase—mediators of lobuloalveolar
morphogenesis
Conditional knockout of Fn, Itgb1, and Fak in mammary epithelium
all compromise the normal development of the lobuloalveolar com-
partment during pregnancy (Li et al., 2005; Nagy et al., 2007; Naylor
et al., 2005; White et al., 2004). To test whether Itgb1 and Fak might
act downstream of Fn, we examined expression of these proteins and
Fig. 9. Fn deletion is associated with decreased neovascularization during lobuloalveolar differentiation. (A) Histological section of the lobuloalveolar compartment of a 15-day
pregnant Fnﬂ/ﬂ mouse stained with anti-CD31 antibody exhibits an intricate capillary network that surrounds alveoli in a honeycomb pattern. Bar: 40 μm. (B) Lobular segment
stained with anti-Fn antibodies shows close association of blood vessels (recognized readily by the grayish-stained red blood cells and arrowheads) with Fn staining and the shaping
of newly forming alveoli. (C) Ductal cross section in a 15-day pregnant FnMEp−/− mouse stained with anti-CD31 antibody exhibits capillaries (arrowheads) embedded in a thick
connective capsules surrounding a small duct. (D) In accordance with A–C, lobuloalveolar development is associated with a strong message for Vegf in mammary glands from Fnﬂ/ﬂ
mice and a weak Vegf message in mammary glands from FnMEp−/− mice. Mean±SE; pb0.05. Bars: 50 μm.
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and FnMEp−/− mice. In pregnant mice, Fn deletion appeared to be
associated with decreased Itgb1 expression and suppressed phosphor-
ylation of FakY397 (Fig. 10). Since this result might be affected by a
compromised lobular compartment in FnMEp−/− mice, we also
measured Itgb1 expression levels in adult, virgin Fnﬂ/ﬂ and FnMEp−/−
mice. Albeit there was no statistical difference in the glandular volume
percent occupying the MFP in these mice, Itgb1 message levels were
signiﬁcantly decreased in 8-week-old, virgin and pregnant FnMEp−/−Fig. 10. Fn deletion suppresses signaling via Itgb1 and Fak during lobuloalveolar
differentiation. Mammary epithelial cells from Fnﬂ+/+ and FnMEp−/− mice were
extracted in lysis buffer and subjected toWestern blotting with anti-Fn, anti-Itgb1, anti-
Fak, and anti-Fak(pY397) antibodies. Mammary epithelial cells from Fnﬂ+/+ mice
exhibit strong Fn, Itgb1, and Fak(pY397) expression, while mammary epithelial cells
from FnMEp−/− mice express reduced levels of Fn, Itgb1 and activated Fak.mice (Suppl. Figs. 2 and 3), suggesting a coregulation of Fn and Itgb1
during mammary gland postnatal development.
Discussion
Fibronectin has been introduced as a multidomain glycoprotein
that regulates a variety of cellular functions including differentiation,
proliferation, apoptosis, and migration (Danen and Yamada, 2001;
ffrench-Constant, 1995; Geiger et al., 2001; Hynes, 1990; Johansson
et al., 1997; Kumar, 1998; Leiss et al., 2008; Pankov and Yamada,
2002; Wierzbicka-Patynowski and Schwarzbauer, 2003). As such, it is
involved in embryologic and postnatal development (George et al.,
1993; Sakai et al., 2003;Watt and Hodivala, 1994), tissue homeostasis,
wound healing, angiogenesis, and cancer (Cheng et al., 2003; Danen
and Yamada, 2001; ffrench-Constant, 1995; Geiger et al., 2001; Hynes,
1990; Johansson et al., 1997; Kumar, 1998; Leiss et al., 2008; Pankov
and Yamada, 2002; Wierzbicka-Patynowski and Schwarzbauer,
2003). Here, we have analyzed the effects of the conditional knockout
of Fn in mammary epithelial cells on postnatal development of
the mammary gland. Studies of adolescent (5 weeks) and adult
virgin (16 weeks) mice of the three phenotypes Fnﬂ/ﬂ, FnMEp+/−, and
FnMEp−/− yieldedquantitative differences in the expansion of theductal
tree within the MFPs of the three groups of mice. Noteworthy are
statistically decreased distances of branch outgrowth and decreased
numbers of branch points and TEBs in 5-week-old FnMEp−/− relative to
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mice but were less pronounced. Statistically sound differences were
observed in pregnant mice, where the mammary glands of FnMEp−/−
mice exhibited deﬁciencies of various degrees in the typical lobuloal-
veolar differentiation observed in Fnﬂ/ﬂ and heterozygous FnMEp+/−
mice (see Figs. 4 and 5). The degree of lobuloalveolar impairment
in FnMEp−/− mice ranged from segmental hypoplasia to aplasia and
was closely associated with the amount of Fn protein recovered from
these glands.
Functionally, delays in ductal outgrowth and lack of alveologenesis
in FnMEp−/− mice were associated with signiﬁcantly decreased rates
of proliferation of Fn-deﬁcientmammary epithelial cells (Fig. 6; Suppl.
Fig. 1). The near compensation of ductal outgrowth from 5- to 16-
week-old FnMEp−/− mice can be explained by the mosaic nature of
Cre expression and the ensuing growth advantage of Fn-positive
over Fn-negative epithelial cells. Similarly, the extent of Cre ex-
pression can also account for the broad range in the degree of im-
paired alveologenesis in pregnant FnMEp−/− mice; i.e., mammary
glands with a high percentile of Cre-expressing epithelial cells fail to
develop a lobuloalveolar department, while mammary glands, in
which only half the epithelial cells are Cre-positive, exhibit only a
mildly hypoplastic lobuloalveolar compartment. This effect is en-
hanced by high levels of Fn expression during pregnancy and
alveologenesis (Woodward et al., 2001) and by a growth advantage
of Fn-positive over Fn-negative mammary epithelial cells. Irrespective
of the problems associated with MMTV-Cre mediated knockout
models (Wagner et al., 1997, 2001), our data are consistent with
experiments in 3-D culture showing that Fn promotes mammary
epithelial cell growth and alveologenesis (Williams et al., 2008).
Moreover, Fn knockdown in the salivary gland epithelium by siRNA as
well as functional anti-Fn and anti-Itgb1 antibodies prevented
alveologenesis in organ culture (Sakai et al., 2003).
Our data mimic those reported for mice with the MMTV-Cre
mediated deletion of Fak in the mammary epithelium (Nagy et al.,
2007). Fak knockout in mammary epithelium, like Fn knockout, did
not affect the pattern of ductal outgrowth and branching, albeit both
were slowed down in FnMEp−/− and FakMEp−/− mice. In pregnant
mice, however, total deletion of either Fn or Fak left only a skeleton of
ducts and ductules (Fig. 4) and was associated with failure in
generating the lobuloalveolar compartment (Nagy et al., 2007).
These data show that neither Fn nor Fak played a major role during
early stages of postnatal mammary gland development (i.e., ductal
outgrowth and branching) but were principals in alveologenesis
(Nagy et al., 2007). A similar pathology, consisting of a decreased
number of alveoli that were disorganized and contained clumps of
epithelial cells bulging into what would normally be luminal space
during pregnancy, has been reported in mice with conditional
knockout of Itgb1 in the mammary epithelium (Naylor et al., 2005).
These alveolar aberrations are consistent with those observed in
FnMEp−/−mice, where alveolar lumina were often ﬁlled entirely with
epithelial cells. In this comparison between Fn-, Itgb1-, and Fak-
conditional knockout inmammary epithelium, it is important to recall
that mammary epithelial deletion of Fn and Fak were mediated by Cre
recombinase under control of the MMTV promoter, while Itgb1
deletion was mediated by Cre under control of the β-lactoglobulin
(Blg) andwhey acidic protein (Wap) promoters, respectively (Li et al.,
2005; Naylor et al., 2005). MMTV-Cre expression in mammary
epithelium, as monitored in ROSA reporter mice, was recorded as
early as 6 days after parturition, while Bgl-Cre was detected in ductal
epithelium of nulliparous mice from the age of 12 weeks and was
extended throughout pregnancy and lactation and Wap-Cre was
speciﬁcally expressed in secretory luminal epithelial cells starting at
mid pregnancy and culminating at day 3 of lactation (Li et al., 2005;
Wagner et al., 2001). Accordingly, the delay in Bgl-mediated Cre
expression relative to that mediated by MMTV may have been
responsible for the less severe effects on the lobuloalveolar compart-ment in Itgb1 knockout mice, while Wap-Cre-mediated Itgb1, as
expected, had no effect on the generation of the lobuloalveolar
compartment during midpregnancy.
In our study, loss of Fn appears to be closely associated with loss of
Itgb1. Based on studies by Woodward et al. (2001), both Fn and
Itga5b1 increase signiﬁcantly from adolescent to virgin adult mice and
remain high during pregnancy in mammary epithelia and myope-
pithelial cells, while their expression levels in the stromal compart-
ment remain more or less constant throughout mammary gland
development (3-week-old mice to lactating mice). Thus, it is possible
that decreased Itgb1 expression is secondary to epithelial and
myopepithelial loss in FnMEp−/− mice. However, the fact that Itgb1
is also signiﬁcantly downregulated in virgin FnMEp−/−mice, in which
we did not observe a statistical difference in the glandular volume
percent occupying the MFP cannot exclude a coregulation of Fn and
Itgb1. To this effect, Woodward et al. (2001) showed that ovariectomy
of virgin adult mice caused a proportional decrease in both Fn and
Itga5b1 and that this effect was reversed by estrogen treatment,
suggesting a hormonal regulation of these two genes. Moreover,
placement of mammary epithelial cells on various ECM substrates in
vitro caused a signiﬁcant increase in DNA synthesis only when placed
on Fn, which, among others, might also have promoted synthesis
and expression of its principal cell surface receptor Itga5b1 (Wood-
ward et al., 1998). The coexpression of Fn and Itga5b1 has also been
recognized in developing and regenerating chick peripheral nerve
(Lefcort et al., 1992). Both Fn and Itga5b1 were expressed at high
levels in developing nerve, but only at low levels in mature nerves.
Following injury of mature nerve, both Fn and Itga5b1 were induced.
These observations correlated with those obtained in mammary
gland development in that both Fn and Itgb1 are upregulated only
during states of high cellular proliferation, i.e., alveologenesis in the
mammary gland and development and regeneration of nerve tissue.
The fact that Fn, Itgb1, and Fak deletion in mammary epithelium
have similar effects on the mammary gland development, combined
with decreased Itgb1 expression and lack of phosphorylation of
FakY397 in mice with Fn conditional knockout, suggest that the
observed pathology may be mediated, at least in part, by a disruption
in the Fn/Itgb1/Fak signaling pathway. Decreased FakY397 phos-
phorylation, which is essential for its full activation (Schlaepfer and
Hunter, 1998), is also noticed in mice with conditional knockout of
Itgb1 in the mammary epithelium (Naylor et al., 2005; White et al.,
2004) and in mice that expressed a dominant-negative chimeric form
of Itgb1 (Faraldo et al., 1998). Thus, disruption of Fn/Itgb1/Fak
signaling and associated malformation of focal adhesions (Naylor
et al., 2005) may have accounted for the observed, dramatically
decreased rates of proliferation (Abbi and Guan, 2002; Li et al., 2005;
Mitra and Schlaepfer, 2006; Nagy et al., 2007; Naylor et al., 2005;
White et al., 2004; Woodward et al., 2001), loss of polarity (Tomar
et al., 2009), and epithelial invasion of mammary gland stroma (Hsia
et al., 2003) during alveologenesis in pregnant FnMEp−/−, Itgb1MEp−/−
and FakMEp−/−mice.
In addition to itsmajor cell growth-promoting role in generating the
lobuloalveolar compartment, Fn appears also to be involved in alveolar
budding in pregnant Fnﬂ/ﬂ mice, inducing cleft formation within the
epithelial lining of an existing alveolus as described in salivary gland
morphogenesis in organ culture (Sakai et al., 2003). Accumulation of Fn
in clefts supports the in-growth of capillary blood vessels, which
separate the new alveolus from the parental one and eventually
surround each alveolus with vascular honeycombs in preparation for
lactation (Djonov et al., 2003). Alternatively, new alveoli may also form
from a cohort of weakly CK8- and Fn-positive mammary epithelial cells
that grow out from the epithelial lining of an existing alveolus in a
polarized fashion and penetrate the surroundingmammary stroma (see
Figs. 8A–F). This epithelial outgrowth involves stromal invasion, matrix
remodeling, and cell proliferation (Fata et al., 2004; Larsen et al., 2006;
Williams et al., 2008) that may well be regulated by Fn and its putative
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2005; White et al., 2004). The following differentiation into mature
alveoli during lactation may then be achieved in an Fn-independent
manner; e.g., Jak2/Stat5a-signaling, which has been reported to be
accompanied by increased expression of ‘epithelial differentiation
genes’ such as E-cadherin, zonula occludens-1, and CK8 and CK18
(Sultanet al., 2008). It is paralleledbyadown-regulation of Fn (Williams
et al., 2008; Adams and Watt, 1989).
High levels of Vegf expression combined with anti-CD31 immu-
nohistochemical analyses underscore the importance of neovascular-
ization in alveologenesis in Fnﬂ/ﬂ mice. It is therefore not surprising
that deletion of Vegf in mammary epithelium (Rossiter et al., 2007)
and expression of the anti-angiogenic splice isoform of Vegf, Vegf165b,
in transgenic mice (Qiu et al., 2008) compromised lobuloalveolar
expansion into the fat pad during pregnancy and lactation and failed
to upregulate genes involved in milk secretion (Rossiter et al., 2007).
Albeit Vegf loss in FnMEp−/− mice could well be associated with a
missing lobuloalveolar compartment, there is increasing evidence of a
regulation of Vegf by Fn, particularly by its EDB+splice variant, in a
variety of tissues in both physiologic and pathologic conditions (Jiang
et al., 1994; Rongish et al., 1996; Khan et al., 2004, 2005) as well as in
vitro (Zhou et al., 2008). The deposition of Fn at the base of alveoli and
its close association with capillary blood vessels in our study (Fig. 9B)
suggests that Fn may provide a scaffolding for the migration of
endothelial cells into areas of alveologenesis.
In conclusion,we have presented novel evidence of the role of Fn in
postnatalmammary glandmorphogenesis. Conditional knockout of Fn
in mammary epithelium leads to lobuloalveolar hypoplasia/aplasia.
This pathology is caused by a signiﬁcantly decreased rate of
proliferation of Fn-deﬁcient mammary epithelial cells (Fig. 6), result-
ing in delayed ductal outgrowth and deﬁcient alveologenesis (Figs. 5D
and E). Preliminary data showing the concomitant down-regulation of
Itgb1 and decreased phosphorylation of FakY397 suggest that this
pathology may, at least in part, be regulated by the disruption of Fn/
Itgb1/Fak signaling. This notion is supported by the fact that
conditional knockouts of Fn, Itgb1, and Fak all affect alveologenesis
during pregnancy (Li et al., 2005; Nagy et al., 2007; Naylor et al., 2005;
White et al., 2004). Further unraveling of the spatial and temporal
expression patterns of Fn and other matrix macromolecules and their
cell surface receptors as well as growth-promoting factors (e.g., cyclin
D, c-myc, HGF, EGF, VEGF) and steroid hormones (e.g., estrogen,
progesterone) and their associated, interacting signaling pathways,
which have all been implicated individually in mammary epithelial
cell proliferation and glandular morphogenesis (reviewed in Hen-
nighausen and Robinson, 2001, 2005; Shillingford and Hennighausen,
2001), will be needed to understand the complex picture of mammary
glandmorphogenesis. These efforts could ultimately harbor new clues
of the role that these factors, particularly Fn, may play in mammary
tumor progression (Haslam andWoodward, 2003; White et al., 2004;
Williams et al., 2008; Huang et al., 2008).
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